Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment

Detalles Bibliográficos
Autores principales: Kazakov, Rossen M, Petrova, Penka I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603611/
http://dx.doi.org/10.1186/2052-3211-8-S1-P17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603611/
http://dx.doi.org/10.1186/2052-3211-8-S1-P17

Ejemplares similares